One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: CIF
This product is a two-way immune regulator which can be used for adjuvant therapy of tuberculosis chemotherapy as a combination drug. "1, The only immune preparations recommended by WHO to treat tuberculosis; 2, The sole manufacturer over the world; 3, The clinical trial for prevention of tuberculosis is in the process. 4, Time to market: 2001 5, Total turnover reached 100 million US dollars in 2013. 6, Exported countries: Vietnam Registration Dossiers:non-clinical & clinical part, drug substance part and drug product part."